Your browser doesn't support javascript.
loading
Dysregulation of microRNA biogenesis machinery in cancer.
Hata, Akiko; Kashima, Risa.
Affiliation
  • Hata A; a Cardiovascular Research Institute, University of California , San Francisco , CA , USA.
  • Kashima R; a Cardiovascular Research Institute, University of California , San Francisco , CA , USA.
Crit Rev Biochem Mol Biol ; 51(3): 121-34, 2016.
Article in En | MEDLINE | ID: mdl-26628006
ABSTRACT
MicroRNAs (miRNAs) are integral to the gene regulatory network. A single miRNA is capable of controlling the expression of hundreds of protein coding genes and modulate a wide spectrum of biological functions, such as proliferation, differentiation, stress responses, DNA repair, cell adhesion, motility, inflammation, cell survival, senescence and apoptosis, all of which are fundamental to tumorigenesis. Overexpression, genetic amplification, and gain-of-function mutation of oncogenic miRNAs ("onco-miRs") as well as genetic deletion and loss-of-function mutation of tumor suppressor miRNAs ("suppressor-miRs") are linked to human cancer. In addition to the dysregulation of a specific onco-miR or suppressor-miRs, changes in global miRNA levels resulting from a defective miRNA biogenesis pathway play a role in tumorigenesis. The function of individual onco-miRs and suppressor-miRs and their target genes in cancer has been described in many different articles elsewhere. In this review, we primarily focus on the recent development regarding the dysregulation of the miRNA biogenesis pathway and its contribution to cancer.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Gene Expression Regulation, Neoplastic / MicroRNAs / Neoplasms Limits: Animals / Humans Language: En Year: 2016 Type: Article

Full text: 1 Database: MEDLINE Main subject: Gene Expression Regulation, Neoplastic / MicroRNAs / Neoplasms Limits: Animals / Humans Language: En Year: 2016 Type: Article